1. Home
  2. TVTX vs GTX Comparison

TVTX vs GTX Comparison

Compare TVTX & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • GTX
  • Stock Information
  • Founded
  • TVTX 2008
  • GTX 2018
  • Country
  • TVTX United States
  • GTX Switzerland
  • Employees
  • TVTX N/A
  • GTX N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • GTX Auto Parts:O.E.M.
  • Sector
  • TVTX Health Care
  • GTX Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • GTX Nasdaq
  • Market Cap
  • TVTX 1.7B
  • GTX 1.9B
  • IPO Year
  • TVTX N/A
  • GTX N/A
  • Fundamental
  • Price
  • TVTX $20.44
  • GTX $11.36
  • Analyst Decision
  • TVTX Strong Buy
  • GTX Strong Buy
  • Analyst Count
  • TVTX 14
  • GTX 1
  • Target Price
  • TVTX $33.31
  • GTX $14.00
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • GTX 2.2M
  • Earning Date
  • TVTX 05-01-2025
  • GTX 05-01-2025
  • Dividend Yield
  • TVTX N/A
  • GTX 1.06%
  • EPS Growth
  • TVTX N/A
  • GTX N/A
  • EPS
  • TVTX N/A
  • GTX 1.28
  • Revenue
  • TVTX $273,533,000.00
  • GTX $3,438,000,000.00
  • Revenue This Year
  • TVTX $68.31
  • GTX N/A
  • Revenue Next Year
  • TVTX $55.65
  • GTX $7.85
  • P/E Ratio
  • TVTX N/A
  • GTX $8.85
  • Revenue Growth
  • TVTX 75.65
  • GTX N/A
  • 52 Week Low
  • TVTX $6.01
  • GTX $7.02
  • 52 Week High
  • TVTX $25.29
  • GTX $10.39
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 61.49
  • GTX 80.19
  • Support Level
  • TVTX $19.84
  • GTX $9.01
  • Resistance Level
  • TVTX $22.07
  • GTX $11.35
  • Average True Range (ATR)
  • TVTX 1.11
  • GTX 0.36
  • MACD
  • TVTX 0.42
  • GTX 0.25
  • Stochastic Oscillator
  • TVTX 77.85
  • GTX 92.50

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About GTX Garrett Motion Inc.

Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.

Share on Social Networks: